Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CRA-2059 is a potent and selective inhibitor of tryptase, particularly targeting recombinant human tryptase-β (rHTβ), with a K i of 620 pM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | CRA-2059 is a potent and selective inhibitor of tryptase, particularly targeting recombinant human tryptase-β (rHTβ), with a K i of 620 pM. |
In vitro | Tryptase, a trypsin-like serine protease prevalent in the secretory granules of human mast cells, is significantly present as a major protein element. CRA-2059 shows promise for research in inflammatory bowel disease [1]. |
Molecular Weight | 750.818 |
Formula | C34H46N12O8 |
CAS No. | 256649-36-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CRA-2059 256649-36-2 CRA2059 CRA 2059 inhibitor inhibit